Using advanced lasers for safer eye surgeries
Optical Coherence Tomography (OCT)-Guided Ultrafast, Nonthermal Laser Microablation for Non-invasive Vitreoretinal Surgery
['FUNDING_FELLOWSHIP'] · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · NIH-11071824
This study is testing a new, gentle laser surgery for eye conditions that affect the retina, aiming to make the procedure safer and help you recover faster.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR (nih funded) |
| Locations | 1 site (COLLEGE STATION, UNITED STATES) |
| Trial ID | NIH-11071824 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new surgical technique using ultrafast, nonthermal lasers to treat eye conditions affecting the retina. By utilizing these advanced lasers, the goal is to perform vitreoretinal surgeries with greater precision and less risk of damage to surrounding tissues compared to traditional thermal lasers. The approach aims to reduce complications and improve recovery times for patients undergoing these delicate procedures. The research will evaluate the effectiveness and safety of this innovative method in treating various retinal disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from vitreoretinal disorders such as age-related macular degeneration or diabetic retinopathy.
Not a fit: Patients with non-retinal eye conditions or those who do not require surgical intervention for their eye issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective treatments for patients with retinal conditions, potentially preserving vision and improving surgical outcomes.
How similar studies have performed: While the use of ultrafast lasers in anterior segment surgeries has been successful, their application in vitreoretinal surgery is largely novel and untested.
Where this research is happening
COLLEGE STATION, UNITED STATES
- TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR — COLLEGE STATION, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KERMANY, DANIEL — TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
- Study coordinator: KERMANY, DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: age related macular disease